On July 7, 2023, Enochian Biosciences Inc. Received A Deficiency Notice From The Nasdaq Stock Market Informing The Company That Its Common Stock, Par Value $0.0001 Per Share, Fails To Comply With The $1 Minimum Bid Price
Portfolio Pulse from Happy Mohamed
Enochian Biosciences Inc. has received a deficiency notice from the Nasdaq Stock Market, indicating that its common stock fails to comply with the $1 minimum bid price.
July 11, 2023 | 8:08 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Enochian Biosciences Inc.'s stock fails to meet the Nasdaq's $1 minimum bid price requirement, which could lead to delisting if not rectified.
Enochian Biosciences Inc.'s stock price is below the Nasdaq's $1 minimum bid price requirement. This could lead to the company's stock being delisted from the Nasdaq if the issue is not rectified within a specified timeframe. Delisting often results in a decrease in the stock's liquidity and may negatively impact its price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100